Microfluidic Market Growth, Size, Industry Trends, By Segment, By Application, Future Outlook, Analysis Report 2022-2027: SPER Market Research
According to SPER Market Research, the Microfluidic Market is rapid return on investment, technical breakthroughs, greater mobility via microfluidic chip downsizing, data precision, correctness in outcomes, and strong demand are the primary drivers of growth. Complex regulatory criteria, however, and the complexity of adopting microfluidics technology, provide considerable challenges.
Microfluidic Market Overview (2022-2027)
- Forecast CAGR (2022-2027): 19.6%
- Forecast Market Size (2027): USD 46.90 Billion
Pre-hospital analysis, such as routine blood glucose level checks, can be performed at home, minimising hospital visits and stays. The introduction of point-of-care diagnostics by multiple market participants resulted in fewer hospital visits and earlier illness diagnosis. With advancements in technology, industry companies may now differentiate their goods by including minimally intrusive features as well as speed and precision. Microfluidics has therefore established itself in the IVD sector.
Impact of COVID-19 on the Global Microfluidic Market:
Rapid diagnosis is still critical in the current COVID-19 treatment. The lengthier timescales required by existing marketed COVID-19 assays, along with the time it takes large-scale laboratories and hospitals to return findings to patients, has opened the path for COVID-19 point-of-care testing. Microfluidics is highly suited for the development of COVID-19 point-of-care testing because it has quick turnaround times, a clinically appropriate detection limit, and results in cost-effective assays.
Request For Free Sample Report @ https://www.sperresearch.com/report-store/Microfluidics.aspx?sample=1
Global Microfluidic Market Key Segments Covered:
The SPER Market Research report seeks to give market dynamics, demand, and supply forecasts for the years up to 2030. This report contains statistics on product type segment growth estimates and forecasts.
By Product,
- microfluidic-based devices
- microfluidic components
By application,
- In vitro diagnostics
- Pharmaceutical
- Life science research
- Manufacturing and therapeutics
By End User,
- Hospitals & diagnostic centres
- Academic & research institutes
- Pharmaceutical & biotechnology companies
By Region:
- North America
- Europe
- Asia-Pacific
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends, and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Global Microfluidic Market Key Players:
The Global Clinical Decision Support System Market study provides market data by the competitive landscape, revenue analysis, market segments, and detailed analysis of key market players such as; Danaher Corporation (US), Thermo Fisher Scientific (US), PerkinElmer Inc. (US), Agilent Technologies (US), Bio-Rad Laboratories Inc. (US), Becton, Dickinson and Company (US), F. Hoffmann-La Roche (Switzerland), Illumina, Inc. (US), Fluidigm Microfluidics (US), Abbott Laboratories (US), QIAGEN (Netherlands), Parker-Hannifin Corporation (US), Fluigent SA (France), Idex Corporation (US), Camozzi Automation Spa Società Unipersonale (Italy), Gems Sensors and Control (US), Aignep S.P.A. (Italy), SMC Corporation (Japan), Dolomite Microfluidics (UK), Cellix Ltd. (Ireland), Elveflow (France), Microfluidic ChipShop (Germany), Micronit Microtechnologies (Netherlands), and MicroLiquid (Spain).
For More Information, refer to below link: –
Microfluidic Market Future Outlook
Related Reports:
Follow Us –
LinkedIn | Instagram | Facebook | Twitter
Contact Us:
SPER Market Research
Smith Williams, Business Consultant – USA
+1-347-460-2899